Stock ODX CAMBRIDGE NUTRITIONAL SCIENCES PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cambridge Nutritional Sciences plc

Equities

ODX

GB00B1VCP282

Medical Equipment, Supplies & Distribution

Market Closed - London S.E.
Other stock markets
 11:35:28 2024-04-26 am EDT 		5-day change 1st Jan Change
3.85 GBX 0.00% Intraday chart for Cambridge Nutritional Sciences plc +18.46% +60.42%
Apr. 22 Cambridge Nutritional Sciences Nonexecutive Chair Steps Down; Successor Named MT
Apr. 22 Cambridge Nutritional Sciences plc Provides Earnings Guidance for the Year Ended 31 March 2024 CI

Valuation

Fiscal Period: Maart 2019 2020 2021 2022 2023 2024
Capitalization 1 16.82 11.47 147 7.033 7.368 9.161
Enterprise Value (EV) 1 17.74 12.34 144 5.683 2.304 4.961
P/E ratio 17.3 x -1.56 x -67.1 x -0.62 x -2.21 x -7.7 x
Yield - - - - - -
Capitalization / Revenue 1.72 x 1.17 x 16.8 x 0.57 x 0.98 x 1.02 x
EV / Revenue 1.82 x 1.26 x 16.5 x 0.46 x 0.31 x 0.55 x
EV / EBITDA 140 x 13.8 x -66.5 x -1.04 x -1.13 x -
EV / FCF -7.63 x -7.68 x -27.5 x -1.21 x -0.7 x -7.09 x
FCF Yield -13.1% -13% -3.64% -82.8% -143% -14.1%
Price to Book 0.92 x 0.79 x 6.02 x 0.61 x 0.74 x 1.04 x
Nbr of stocks (in thousands) 126,959 150,387 182,570 182,682 237,685 237,951
Reference price 2 0.1325 0.0762 0.8050 0.0385 0.0310 0.0385
Announcement Date 9/23/19 7/14/20 7/13/21 9/12/22 8/3/23 -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2019 2020 2021 2022 2023 2024
Net sales 1 9.759 9.819 8.735 12.33 7.546 9
EBITDA 1 0.1263 0.893 -2.165 -5.469 -2.046 -
EBIT 1 -0.2062 -0.3132 -2.932 -6.653 -2.528 -0.6
Operating Margin -2.11% -3.19% -33.57% -53.97% -33.5% -6.67%
Earnings before Tax (EBT) 1 1.183 -8.298 -3.54 -10.5 -3.252 -1.2
Net income 1 0.9742 -6.828 -2.104 -11.33 -3.172 -1.2
Net margin 9.98% -69.54% -24.09% -91.93% -42.04% -13.33%
EPS 2 0.007660 -0.0490 -0.0120 -0.0620 -0.0140 -0.005000
Free Cash Flow 1 -2.326 -1.606 -5.244 -4.707 -3.305 -0.7
FCF margin -23.83% -16.36% -60.04% -38.18% -43.8% -7.78%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 9/23/19 7/14/20 7/13/21 9/12/22 8/3/23 -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2024 S1 2024 S2
Net sales - -
EBITDA - -
EBIT - -
Operating Margin - -
Earnings before Tax (EBT) 1 - -0.46
Net income 1 -0.698 -0.46
Net margin - -
EPS 2 -0.003000 -0.002000
Dividend per Share - -
Announcement Date 11/23/23 -
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt 1 0.92 0.87 - - - -
Net Cash position 1 - - 2.99 1.35 5.06 4.2
Leverage (Debt/EBITDA) 7.298 x 0.9735 x - - - -
Free Cash Flow 1 -2.33 -1.61 -5.24 -4.71 -3.31 -0.7
ROE (net income / shareholders' equity) -1.55% -2.91% -11.3% -39.3% -29.1% -6.8%
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share 2 0.1400 0.1000 0.1300 0.0600 0.0400 0.0400
Cash Flow per Share - - - - - -
Capex 1 2.69 2.15 2.82 1.48 0.15 0.2
Capex / Sales 27.61% 21.94% 32.34% 11.99% 2.03% 2.22%
Announcement Date 9/23/19 7/14/20 7/13/21 9/12/22 8/3/23 -
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Cambridge Nutritional Sciences plc

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
CAMBRIDGE NUTRITIONAL SCIENCES PLC Stock Cambridge Nutritional Sciences plc
+60.42% 11.41M
BIOMÉRIEUX Stock bioMérieux
+0.89% 12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-10.29% 7.61B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+1.78% 5.41B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-1.16% 4.51B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+5.74% 4.49B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-50.70% 3.29B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+12.21% 2.73B
VITROLIFE AB Stock Vitrolife AB
-16.13% 2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-11.50% 1.73B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. ODX Stock
  4. Financials Cambridge Nutritional Sciences plc